TrialClinical pharmacokinetics2019

Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes.

Charlotte Granhall et al.PubMed ↗Publisher ↗

No numbers read from the abstract.